Official ESCRS | European Society of Cataract & Refractive Surgeons


First real-world experience with a new monofocal lens design

Search Title by author or title

Session Details

Session Title: Monofocal IOLs: New Biomaterials & Visual Performance

Session Date/Time: Tuesday 17/09/2019 | 16:30-18:00

Paper Time: 17:00

Venue: Free Paper Forum: Podium 2

First Author: : W.Goslings THE NETHERLANDS

Co Author(s): :    J. Van de Laar   A. Dekker                          

Abstract Details


To present clinical data of best corrected distance visual acuity (CDVA), defocus curve and first patient experiences for intermediate distance activities after implantation of the new monofocal Tecnis© Eyhance IOL, ICB00 (Johnson & Johnson Vision (J&JV))


1. Department of Ophthalmology, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands and 2. Lasikcentrum, Boxtel, The Netherlands


50 eyes of 25 standard cataract patients with minimal to no corneal astigmatism (≤ 1.0) were operated bilaterally by phaco emulsification (Signature Pro, J&JV) and a Tecnis© Eyhance IOL, ICB00, was implanted. Corrected distance visual acuity (CDVA) and defocus curves were measured. Patients were questioned for spectacle dependence for intermediate distance activities.


Average corrected distance visual acuity (CDVA) was 1.02 Snellen (≥20/20). The defocus curve showed a broad and relatively flat profile: CDVA: 0.83, (S+0.5), CDVA: 1.02, (S 0), CDVA: 0.95, (S-0.5), CDVA: 0.81, (S-1), CDVA: 0.62, (S-1.5), CDVA: 0.50, (S-2). Many patients reported on spectacle independence for activities in the intermediate range such as reading a computer or tablet, seeing price tags/ shopping, driving/also at night, cooking/ eating, seeing uneven surfaces while walking, particularly going downstairs. The dysphotopsia profile of the ICB00 was similar as its predecessor the Tecnis© ZCB00 IOL


The Tecnis© Eyhance IOL is the latest Tecnis IOL innovation in the monofocal IOL category. As compared with other monofocal IOLs currently available patients implanted with the Tecnis© Eyhance IOL, ICB00, benefit from: improved intermediate vision, 20/20 distance vision and a similar dysphotopsia profile as the ZCB00

Financial Disclosure:

gains financially from product or procedure presented

Back to previous